Diagnostic Utility and Prognostic Significance of Circulating Tumor Cell Assay CNSide in Patients With Suspicion for Leptomeningeal Metastases - Part 1
In the first part of this series, Dr. Justin Abbatemarco and Dr. Shreya Louis discuss the background and evolving terminology around circulating tumor DNA, cell‑free DNA and CSF‑based testing in…
Read the full articleYou might also wanna read
ctDNA-Guided Intraventricular Therapy for CNS Malignancies
Conditions : Leptomeningeal Disease; Glioblastoma; Brain Metastases; Non-Small Cell Lung Cancer; Breast Cancer Interventions : Device: CSF c
MRD Assessment May Refine Prognosis After CAR-T for Follicular Lymphoma
(MedPage Today) -- A study presented at the American Society of Clinical Oncology (ASCO) annual meeting suggested that circulating tumor (ct
Shrinidhi Nathany: New ASCO 2026 ctDNA Clinical Practice Guideline
Shrinidhi Nathany, Consultant Molecular Hematology and Oncology at Fortis Memorial Research Institute, India, shared a post on LinkedIn: “Ne
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Nature, Published online: 01 July 2026; doi:10.1038/s41586-026-10641-1 Integrated multi-omic profiling of glioblastoma reveals GPNMB as a sh
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy
Methylation-based ctDNA monitoring in 57 patients closely reflects outcomes in ER+, HER2- metastatic breast cancer during CDK4/6 inhibitor t
Early Screening for Multiple Myeloma Based on Liquid Biopsy cfDNA Fragmentomics
Conditions : Multiple Myeloma (MM); Smoldering Multiple Myeloma (SMM); MGUS Sponsors : The First Affiliated Hospital with Nanjing Medical Un
Comments
Sign in to join the conversation.
No comments yet. Be the first.